Status:

WITHDRAWN

Hydroxychloroquine or Diltiazem-Niclosamide for the Treatment of COVID-19

Lead Sponsor:

University Hospital, Lille

Collaborating Sponsors:

I-site University Lille North Europe

Conditions:

Sars-CoV2

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

No optimal antiviral intervention has been yet validated to treat COVID-19 disease. Comorbidities, such as older age, obesity, diabetes, history of cardiovascular diseases are associated with poor pro...

Eligibility Criteria

Inclusion

  • Positive SARS-CoV-2 test on nasopharyngeal swab
  • Onset of symptoms \<8 days prior to randomization
  • NEWS score\<4 AND no item ≥2
  • At least one comorbidity among: age ≥ 70 years old, history of cardiac disease, diabetes, obesity, chronic kidney disease, chronic respiratory failure, immunosuppression, neoplasia, liver failure (stage ≥ Child-Pugh B)
  • Fully able to understand the challenges of the trial
  • Signed informed consent
  • Covered by Health Insurance

Exclusion

  • For all patients:
  • Inability to decide to participate
  • Pregnancy or breath feeding
  • Hypersensitivity to any of the test drugs
  • stage 4 or 5 chronic kidney disease (DFG \<30 mL/min/1.73 m²)
  • For hydroxychloroquine arm:
  • Long QT syndrome or QTc space \>500 ms
  • Treatment with piperazine, halofantrine, dasatinib, nilotinib, citalopram, escitalopram, hydroxyzine, domperidone
  • Hepatic porphyria, retinopathy, known glucose-6-phosphate dehydrogenase deficiency,
  • Heart rate \<50/min
  • hypokaliemia \< 3.5 mmol/L
  • For diltiazem arm:
  • Heart rate\<40/min
  • Sinus bradycardia, second- or third-degree atrioventricular block
  • Left heart insufficiency with pulmonary stasis
  • Treatment with dantrolene, pimozide, dihydroergotamine, ergotamine, nifedipine, ivabradine, esmolol, bêta-blockers (bisoprolol, carvedilol, metoprolol, nebivolol), fingolimod

Key Trial Info

Start Date :

May 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2023

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04372082

Start Date

May 1 2020

End Date

May 1 2023

Last Update

March 11 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.